In one study, renal cell carcinoma and NK cell-transplanted NSG mice were treated with carbonic anhydrase IX (CAIX)-targeted CAR T-cells that secrete anti-PD-L1 antibodies. This evidence concerns the gene CA9 and renal cell carcinoma.